Quarterly Result23 May 2026, 08:21 pm
Sai Parenterals FY26 Revenue Up 140.37% to ₹380.99 Cr
AI Summary
Sai Parenterals Ltd (SPL) announced its audited financial results for the quarter and year ended March 31, 2026. Q4 FY26 revenue stood at ₹197.93 crores, up 166.65% QoQ, with EBITDA at ₹28.97 crores (up 366.97% QoQ) and PAT at ₹13.25 crores (up 736.04% QoQ). FY26 revenue reached ₹380.99 crores, a 140.37% YoY increase, with EBITDA at ₹47.21 crores (up 33.29% YoY) and PAT at ₹14.37 crores (up 45.52% YoY). Standalone revenue for FY26 was ₹164.99 crores, up 30.65% YoY.
Key Highlights
- Q4 FY26 revenue grew by 166.65% QoQ to ₹197.93 crores.
- FY26 revenue increased by 140.37% YoY to ₹380.99 crores.
- Standalone revenue for FY26 reached ₹164.99 crores, up 30.65% YoY.
- Acquisition of 74.6% stake in Noumed (Australia) on November 12, 2025.
- 88 product dossiers added in regulated and emerging markets in FY26.
Price Impact
More from SAIPARENT